Elastography Imaging Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Elastography 
Imaging Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  t he  l a tes t  r epo r t  by  IM ARC Group,  t i t l ed  " El as tography I mag ing  
Market :  G l oba l  Indust ry  T rends ,  Share ,  S ize ,  Growth ,  O pportun i ty  and  
Forecast  2024-2032, "  t he  g loba l  e las tog raphy  imag ing  marke t  s i ze  reached  US$ 
4 , 175 .1  M i l l i on  in  2023.
Factors Af fect ing  the  Growth  of  the Elastography Imaging Industry:
Report Signi f icant  Technologica l  Advancements:
Techno log ica l  advancement s  p lay  a  c ruc ia l  r o le  i n  d r i v ing  the  e las tog raphy  
Highlight and imag ing  marke t .  One  s ign i f i can t  advancemen t  i s  t he  i n t eg ra t ion  o f  a r t i f i c ia l  i n t e l l i gence (A I )  and  m ach ine  l ea rn ing  (ML)  a lgo r i t hms ,  wh ich  enhance  image  
process ing  and  in te rpre ta t ion  accu racy .  A I -d r i ven  so f t ware  can  ana l yze  
Description e las tog raphy  im ages  in  r ea l - t ime ,  p rov id ing  imm ed ia te  d iagnos t i c  ins igh ts  and  
reduc ing  the  l i ke l i hood o f  human  e r ro r .  
Add i t i ona l l y ,  A I  can  he lp  in  au t omat i ng  the  image  acqu is i t i on  p rocess ,  mak ing  i t  
more  cons i s t en t  and  rep roduc ib le .  Th is  t echno log i ca l  p rogress ion  has  l ed  t o  
improved  d iagnos t i c  capab i l i t i es ,  par t i cu la r l y  in  de tec t ing  and  charac te r i z ing  l i ve r  
f i b ros is ,  t um ors ,  and  o the r  t i s sue  abnormal i t ies .
Rising Prevalence of  Chronic Diseases:
The r i s ing  p reva lence  o f  ch ron ic  d i seases ,  pa r t i cu la r ly  l i ve r  d iseases  and  
cance r ,  s ign i f i can t ly  d r i ves  the  demand fo r  e las tography  imag ing .  L ive r  
d iseases  such  as  hepa t i t i s ,  fa t t y  l i ve r  d isease ,  and  c i r rhos is  a re  becoming  
inc reas ing ly  common due  to  l i f es t y le  changes  and  the  r i s ing  inc idence  o f  
obes i t y  and  d iabe tes .  E las tography  imag ing  is  a  non- invas ive  method  tha t  
Report prov ides  quan t i ta t i ve  assessmen ts  o f  l i ve r  s t i f fness ,  wh ich  is  c ruc ia l  f o r  ea r ly  
de tec t ion  and  mon i to r ing  o f  l i ve r  f i b ros is .  Th is  ea r l y  de tec t ion  can  lead  to  
Highlight and t ime ly  in te rven t ion  and  be t te r  d i sease  managemen t ,  reduc ing  the  bu rden  on  hea l thcare  sys tems.  Cancer  d iagnos is  and  mon i to r ing  a lso  bene f i t  f rom 
e las tography  imag ing .  
Description Tumors  o f ten  exh ib i t  d i f f e ren t  mechan ica l  p rope r t ies  compared  to  su r round ing  
hea l thy  t i ssues .  E las tography  can  d i f f e ren t ia te  be tween  ben ign  and  ma l ignan t  
les ions  by  measu r ing  t i ssue  s t i f f ness ,  a id ing  in  accura te  d iagnos is  w i thou t  t he  
need  fo r  invas ive  p rocedures  such  as  b iops ies .  The  g row ing  awareness  abou t  
cance r  and  the  impor tance  o f  ea r ly  de tec t ion  have  led  to  increased  u t i l i za t ion  
o f  e las tography  in  onco logy.  As  the  g loba l  bu rden  o f  ch ron ic  d iseases  
con t inues  to  r i se ,  the  demand  fo r  e f fec t i ve ,  non- invas ive  d iagnost i c  t oo ls  such  
as  e las tog raphy  imag ing  i s  expec ted  to  g row,  d r iv ing  marke t  expans ion .
Increasing Adopt ion in Emerging Markets :
The inc reas ing  adop t ion  o f  e las tography  imag ing  in  emerg ing  marke ts  i s  a  
s ign i f i can t  fac to r  d r iv ing  marke t  g rowth .  Coun t r ies  in  As ia -Pac i f i c ,  La t in  
Amer ica ,  and  the  Midd le  East  a re  exper ienc ing  rap id  economic  g rowth ,  l ead ing  
to  imp roved  hea l thcare  in f ras t ruc tu re  and  inc reased  hea l thcare  spend ing .  As  
these  reg ions  inves t  in  advanced  med ica l  techno log ies ,  e las tography  imag ing  
Report i s  becoming  more  access ib le  to  a  b roade r  popu la t ion .  Gove rnment  in i t i a t i ves  
to  imp rove  hea l thcare  se rv i ces  and  the  g rowing  p resence  o f  p r i va te  hea l thca re  
Highlight and prov iders  con t r ibu te  to  the  adop t ion  o f  advanced  d iagnos t ic  t oo ls .  
Emerg ing  marke ts  a l so  face  a  h igh  burden  o f  ch ron ic  d i seases ,  s imi la r  to  
deve loped  reg ions .  The  p reva lence  o f  l i ve r  d iseases ,  cancer ,  and  
Description card iovascu la r  d i seases  is  on  the  r i se ,  necess i ta t ing  e f fec t i ve  d iagnos t ic  
so lu t ions .  The  a f fo rdab i l i t y  and  non- invas ive  na tu re  o f  e las tography  imag ing  
make  i t  an  a t t rac t ive  op t ion  fo r  these  marke ts .  Add i t iona l ly ,  t he  inc reas ing  
awareness  and  educa t ion  abou t  t he  bene f i t s  o f  ea r ly  d isease  de tec t ion  and  
mon i to r ing  a re  d r iv ing  the  demand fo r  e las tog raphy  sys tems.
Request  for  a  PDF sample  o f  th is  repor t :  
h t tps : / /www. imarcgroup .com/e las tog raphy- imag ing-marke t / reques tsamp le
Report Description
Global  E lastography Imaging Market  Trends:
Ano t h e r  key  f ac t o r  d r i v i ng  t h e  e las t o g r ap hy  im ag ing  m ar k e t  i s  t he  i nc r e as ing  ge r i a t r i c  pop u la t i on  w o r ldw i de .  A s  
i nd i v idu a l s  age ,  t h ey  a r e  m or e  l i ke l y  t o  s u f f e r  f r o m  co nd i t i o ns  su ch  a s  l i ve r  f i b r os i s ,  ch r o n i c  l i ve r  d i s eases ,  an d  can ce r s ,  
wh ich  r equ i r e  acc u r a t e  and  n on - inv as i ve  d iagno s t i c  t o o l s .  E las t og r aph y  im ag ing ,  b y  p r ov id ing  p r ec i s e  m eas u r em en t  o f  
t i s sue  s t i f f ness ,  be com e s  c r uc ia l  i n  t h e  ea r l y  de t ec t io n  an d  m a nagem en t  o f  t hese  age - r e la t ed  d i sease s .  
Add i t io na l l y ,  t he  g r ow ing  em pha s i s  on  pe r s ona l i ze d  m e d ic ine  and  t a i l o r e d  t r ea t m e n t  p la ns  ne cess i t a t es  adva nced  im ag i ng  
t ech n iques  su ch  as  e las t og r a phy  t ha t  can  o f f e r  de t a i le d  i ns igh t s  i n t o  t i s sue  p r o pe r t ie s .  The  ex pand in g  app l i c a t i ons  o f  
e las t o g r ap hy  i n  v a r i ou s  m ed ica l  s pec ia l t i es ,  i n c lud in g  ca r d io logy  and  m uscu loske l e t a l  d i s o r de r s ,  f u r t he r  p r ope l  m ar ke t  
g r ow t h .  Fo r  i ns t a nce ,  i n  c a r d io logy ,  e la s t og r a phy  i s  i nc r ea s ing l y  use d  t o  asse ss  m yoca r d ia l  s t i f f n ess ,  a id ing  i n  t h e  
d iagno s i s  o f  hea r t  d i sease s .
Look i ng  f o rw ar d ,  t h e  mark e t  t o  reach  US$  8 , 1 05 . 7  M i l l i on  b y  2032 ,  exh i b i t i ng  a  g row t h  ra t e  ( C AG R)  o f  7 . 65%  d ur i n g  
2024 - 203 2 .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / e l as t o graph y- i m ag i ng- ma rke t
Breakup by Modality:
• Ultrasound
• Magnet ic Resonance
Breakup by Application:
• Radiology
Report • Cardiology
• Obstetr ics
Segmentation
• Urology
• Vascular
• Orthopedic and Musculoskeletal
• Others
Breakup by End Use:
• Hospitals
• Ambulatory Surgery Centers
• Others
Breakup by Region:
• North America
Report • Europe
• Asia-Pacifi c
Segmentation • Latin America
• Middle East and Afr ica
• Canon Medical  Systems Corporation 
(Canon Inc.)
• Esaote SpA
• Fuj ifi lm Holdings Corporation
Competitive 
• GE HealthCare
Landscape • Hitachi , Ltd.
with Key • Hologic, Inc.
• Shenzhen Mindray Bio-Medical  Electronics 
Players Co.,  Ltd.
• Siemens Healthineers AG (Siemens AG)
• SonoScape Medical  Corp
How has the global elastography imaging market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the global elastography imaging market?
Key What is the impact of each driver, restraint, and 
opportunity on the global elastography imaging 
market?
Questions 
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive 
elastography imaging market?
What is the breakup of the market based on the 
modality?
Which is the most attractive modality in the 
elastography imaging market?
What is the breakup of the market based on the 
application?
Which is the most attractive application in the 
elastography imaging market?
Key 
What is the breakup of the market based on the end 
use?
Questions 
Answered in Which is the most attractive end use in the elastography imaging market?
the Report
What is the competitive structure of the global 
elastography imaging market?
Who are the key players/companies in the global 
elastography imaging market?
1     P r e f a c e
2  S c o p e  a n d  M e t h o d o l o g y
2 . 1  O b j e c t i v e s  o f  t h e  S t u d y
2 . 2  S t a k e h o l d e r s
2 . 3  D a t a  S o u r c e s
2 . 3 . 1  P r i m a r y  S o u r c e s
2 . 3 . 2  S e c o n d a r y  S o u r c e s
2 . 4  M a r k e t  E s t i m a t i o n
2 . 4 . 1  B o t t o m - U p  A p p r o a c h
Table of 2 . 4 . 2  T o p - D o w n  A p p r o a c h2 . 5  F o r e c a s t i n g  M e t h o d o l o g y
3  E x e c u t i v e  S u m m a r y
4  G l o b a l  E l a s t o g r a p h y  I m a g i n g  M a r k e t -  I n t r o d u c t i o n
4 . 1  O v e r v i e w
Contents 4 . 2  M a r k e t  D y n a m i c s4 . 3  I n d u s t r y  T r e n d s
4 . 4  C o m p e t i t i v e  I n t e l l i g e n c e
5  G l o b a l  E l a s t o g r a p h y  I m a g i n g  M a r k e t  L a n d s c a p e
5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6  G l o b a l  E l a s t o g r a p h y  I m a g i n g  M a r k e t -  B r e a k u p  b y  M o d a l i t y
6 . 1  U l t r a s o u n d
6 . 1 . 1  O v e r v i e w
6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 2  M a g n e t i c  R e s o n a n c e
6 . 2 . 1  O v e r v i e w
6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 2 . 3  M a r k e t  S e g m e n t a t i o n
6 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
6 . 3  A t t r a c t i v e  I n v e s t m e n t  P r o p o s i t i o n  b y  M o d a l i t y
7  G l o b a l  E l a s t o g r a p h y  I m a g i n g  M a r k e t  -  B r e a k u p  b y  A p p l i c a t i o n
7 . 1  R a d i o l o g y
7 . 1 . 1  O v e r v i e w
7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 1 . 3  M a r k e t  S e g m e n t a t i o n
7 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 2  C a r d i o l o g y
7 . 2 . 1  O v e r v i e w
7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
Table of 7 . 2 . 3  M a r k e t  S e g m e n t a t i o n7 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 3  O b s t e t r i c s
7 . 3 . 1  O v e r v i e w
Contents 7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 3 . 3  M a r k e t  S e g m e n t a t i o n
7 . 3 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 4  U r o l o g y
7 . 4 . 1  O v e r v i e w
7 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 4 . 3  M a r k e t  S e g m e n t a t i o n
7 . 4 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 5  V a s c u l a r
7 . 5 . 1  O v e r v i e w
7 . 5 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 5 . 3  M a r k e t  S e g m e n t a t i o n
7 . 5 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /e la s to gra phy - im a g i ng -m a rke t / t o
c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: